ArticleNeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics2022

Correction to: Vildagliptin Attenuates Huntington's Disease Through Activation of GLP-1 Receptor/PI3K/Akt/BDNF Pathway in 3-Nitropropionic Acid Rat Model.

Noha H Sayed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.